Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

被引:0
作者
Maria Pelayo-Teran, Jose [1 ]
Suarez-Pinilla, Paula [1 ]
Chadi, Nicholas [3 ]
Crespo-Facorro, Benedicto [1 ,2 ]
机构
[1] Univ Cantabria, Dept Psychiat, IFIMAV, Hosp Univ Marques de Valdecilla,Sch Med, Santander 39008, Spain
[2] Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain
[3] McGill Univ, Fac Med, Montreal, PQ H3G 1Y6, Canada
关键词
Schizophrenia; cannabinoids; gene-environment interaction; genetics; CB1; causality; COMT; CATECHOL-O-METHYLTRANSFERASE; SCHIZOPHRENIA-SPECTRUM DISORDERS; HETEROZYGOUS NEUREGULIN-1 MICE; BDNF VAL66MET POLYMORPHISM; NEUROLOGICAL SOFT SIGNS; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; HIGH-RISK; DOPAMINE RELEASE; DEVELOPMENTAL EXPRESSION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabis use may be considered as an additional risk factor in a diathesis-stress model of schizophrenia where the risk of developing the illness would be higher in genetic vulnerable people. In this regard, much of the research on cannabis and psychosis is currently focusing on gene-environment interactions. The present review will focus on the interaction between genes and cannabis exposure in the development of psychotic symptoms and schizophrenia and the biological mechanisms of cannabis. Cannabis use has been shown to act together with other environmental factors such as childhood trauma or urbanicity producing synergistic dopamine sensitization effects. Studies on gene-environment interaction have mainly included genetic variants involved in the regulation of the dopaminergic system. The most promising genetic variants in this field are COMT, CNR1, BDNF, AKT1 and NRG1. Additionally, the interaction with other environmental factors and possible gene-gene interactions are considered in the etiological model.
引用
收藏
页码:5024 / 5035
页数:12
相关论文
共 164 条
  • [31] Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain
    Costas, Javier
    Sanjuan, Julio
    Ramos-Rios, Ramon
    Paz, Eduardo
    Agra, Santiago
    Tolosa, Amparo
    Paramo, Mario
    Brenlla, Julio
    Arrojo, Manuel
    [J]. SCHIZOPHRENIA RESEARCH, 2011, 127 (1-3) : 22 - 27
  • [32] Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model
    Cougnard, Audrey
    Marcelis, Machteld
    Myin-Germeys, Inez
    De Graaf, Ron
    Vollebergh, Wilma
    Krabbendam, Lydia
    Lieb, Roselind
    Wittchen, Hans-Ulrich
    Henquet, Cecile
    Spauwen, Janneke
    Van Os, Jim
    [J]. PSYCHOLOGICAL MEDICINE, 2007, 37 (04) : 513 - 527
  • [33] Low-activity allele of Catechol-O-Methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis
    Crespo-Facorro, Benedicto
    Roiz-Santianez, Roberto
    Maria Pelayo-Teran, Jose
    Perez-Iglesias, Rocio
    Carrasco-Marin, Eugenio
    Mata, Ignacio
    Gonzalez-Mandly, Andres
    Jorge, Ricardo
    Luis Vazquez-Barquero, Jose
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (07) : 1514 - 1518
  • [34] Cannabis and anxiety: a critical review of the evidence
    Crippa, Jose Alexandre
    Zuardi, Antonio Waldo
    Martin-Santos, Rocio
    Bhattacharyya, Sagnik
    Atakan, Zerrin
    McGuire, Philip
    Fusar-Poli, Paolo
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (07) : 515 - 523
  • [35] Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
    D'Souza, DC
    Abi-Saab, WM
    Madonick, S
    Forselius-Bielen, K
    Doersch, A
    Braley, G
    Gueorguieva, R
    Cooper, TB
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (06) : 594 - 608
  • [36] The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
    D'Souza, DC
    Perry, E
    MacDougall, L
    Ammerman, Y
    Cooper, T
    Wu, YT
    Braley, G
    Gueorguieva, R
    Krystal, JH
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) : 1558 - 1572
  • [37] Cannabis and psychosis/schizophrenia: human studies
    D'Souza, Deepak Cyril
    Sewell, Richard Andrew
    Ranganathan, Mohini
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (07) : 413 - 431
  • [38] Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans
    D'Souza, Deepak Cyril
    Pittman, Brian
    Perry, Edward
    Simen, Arthur
    [J]. PSYCHOPHARMACOLOGY, 2009, 202 (04) : 569 - 578
  • [39] Cannabinoids and psychosis
    D'Souza, Deepak Cyril
    [J]. INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 : 289 - +
  • [40] Studies on [3H]CP-55940 binding in the human central nervous system:: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
    Dean, B
    Sundram, S
    Bradbury, R
    Scarr, E
    Copolov, D
    [J]. NEUROSCIENCE, 2001, 103 (01) : 9 - 15